The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Subcutaneous Medicine Delivery Devices Market Research Report 2025
Synopsis
The subcutaneous medicine delivery device is a method, formula, technology and system that transports pharmaceutical compounds into the body at the subcutaneous interface as needed to safely achieve its expected therapeutic effect.
The global Subcutaneous Medicine Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Medicine Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Medicine Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Subcutaneous Medicine Delivery Devices include Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Medicine Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Medicine Delivery Devices.
Report Scope
The Subcutaneous Medicine Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Medicine Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Medicine Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
BD
West Pharmaceutical Services
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Segment by Type
Implantable Subcutaneous Medicine Delivery Device
Injection Type Subcutaneous Medicine Delivery Device
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Medicine Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Medicine Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The subcutaneous medicine delivery device is a method, formula, technology and system that transports pharmaceutical compounds into the body at the subcutaneous interface as needed to safely achieve its expected therapeutic effect.
The global Subcutaneous Medicine Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Medicine Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Medicine Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Subcutaneous Medicine Delivery Devices include Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Medicine Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Medicine Delivery Devices.
Report Scope
The Subcutaneous Medicine Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Medicine Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Medicine Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
BD
West Pharmaceutical Services
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Segment by Type
Implantable Subcutaneous Medicine Delivery Device
Injection Type Subcutaneous Medicine Delivery Device
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Medicine Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Medicine Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Subcutaneous Medicine Delivery Devices Market Overview
1.1 Product Overview and Scope of Subcutaneous Medicine Delivery Devices
1.2 Subcutaneous Medicine Delivery Devices Segment by Type
1.2.1 Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Implantable Subcutaneous Medicine Delivery Device
1.2.3 Injection Type Subcutaneous Medicine Delivery Device
1.3 Subcutaneous Medicine Delivery Devices Segment by Application
1.3.1 Global Subcutaneous Medicine Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Medicine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Medicine Delivery Devices Revenue 2019-2030
1.4.2 Global Subcutaneous Medicine Delivery Devices Sales 2019-2030
1.4.3 Global Subcutaneous Medicine Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Subcutaneous Medicine Delivery Devices Market Competition by Manufacturers
2.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Subcutaneous Medicine Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Subcutaneous Medicine Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Product Type & Application
2.7 Subcutaneous Medicine Delivery Devices Market Competitive Situation and Trends
2.7.1 Subcutaneous Medicine Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Subcutaneous Medicine Delivery Devices Players Market Share by Revenue
2.7.3 Global Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Medicine Delivery Devices Retrospective Market Scenario by Region
3.1 Global Subcutaneous Medicine Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Subcutaneous Medicine Delivery Devices Global Subcutaneous Medicine Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Subcutaneous Medicine Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Subcutaneous Medicine Delivery Devices Sales by Region: 2025-2030
3.3 Global Subcutaneous Medicine Delivery Devices Global Subcutaneous Medicine Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Subcutaneous Medicine Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Subcutaneous Medicine Delivery Devices Revenue by Region: 2025-2030
3.4 North America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.4.1 North America Subcutaneous Medicine Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Subcutaneous Medicine Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Medicine Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Subcutaneous Medicine Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Subcutaneous Medicine Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Medicine Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Medicine Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Subcutaneous Medicine Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Subcutaneous Medicine Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Subcutaneous Medicine Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Subcutaneous Medicine Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Subcutaneous Medicine Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Subcutaneous Medicine Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Subcutaneous Medicine Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Subcutaneous Medicine Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Subcutaneous Medicine Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Subcutaneous Medicine Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Subcutaneous Medicine Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Eli Lily
6.2.1 Eli Lily Corporation Information
6.2.2 Eli Lily Description and Business Overview
6.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolio
6.2.5 Eli Lily Recent Developments/Updates
6.3 Galaxo
6.3.1 Galaxo Corporation Information
6.3.2 Galaxo Description and Business Overview
6.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolio
6.3.5 Galaxo Recent Developments/Updates
6.4 HMD pharmaceuticals
6.4.1 HMD pharmaceuticals Corporation Information
6.4.2 HMD pharmaceuticals Description and Business Overview
6.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolio
6.4.5 HMD pharmaceuticals Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Subcutaneous Medicine Delivery Devices Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Subcutaneous Medicine Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Corporation Information
6.11.2 Zogenix Subcutaneous Medicine Delivery Devices Description and Business Overview
6.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
6.12 BD
6.12.1 BD Corporation Information
6.12.2 BD Subcutaneous Medicine Delivery Devices Description and Business Overview
6.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BD Subcutaneous Medicine Delivery Devices Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 West Pharmaceutical Services
6.13.1 West Pharmaceutical Services Corporation Information
6.13.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Description and Business Overview
6.13.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolio
6.13.5 West Pharmaceutical Services Recent Developments/Updates
6.14 Ypsomed AG
6.14.1 Ypsomed AG Corporation Information
6.14.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Description and Business Overview
6.14.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolio
6.14.5 Ypsomed AG Recent Developments/Updates
6.15 Elcam Medical
6.15.1 Elcam Medical Corporation Information
6.15.2 Elcam Medical Subcutaneous Medicine Delivery Devices Description and Business Overview
6.15.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolio
6.15.5 Elcam Medical Recent Developments/Updates
6.16 Amgen
6.16.1 Amgen Corporation Information
6.16.2 Amgen Subcutaneous Medicine Delivery Devices Description and Business Overview
6.16.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Amgen Subcutaneous Medicine Delivery Devices Product Portfolio
6.16.5 Amgen Recent Developments/Updates
6.17 Wilhelm Haselmeier
6.17.1 Wilhelm Haselmeier Corporation Information
6.17.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Description and Business Overview
6.17.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolio
6.17.5 Wilhelm Haselmeier Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Medicine Delivery Devices Industry Chain Analysis
7.2 Subcutaneous Medicine Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Medicine Delivery Devices Production Mode & Process
7.4 Subcutaneous Medicine Delivery Devices Sales and Marketing
7.4.1 Subcutaneous Medicine Delivery Devices Sales Channels
7.4.2 Subcutaneous Medicine Delivery Devices Distributors
7.5 Subcutaneous Medicine Delivery Devices Customers
8 Subcutaneous Medicine Delivery Devices Market Dynamics
8.1 Subcutaneous Medicine Delivery Devices Industry Trends
8.2 Subcutaneous Medicine Delivery Devices Market Drivers
8.3 Subcutaneous Medicine Delivery Devices Market Challenges
8.4 Subcutaneous Medicine Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Subcutaneous Medicine Delivery Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Subcutaneous Medicine Delivery Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Subcutaneous Medicine Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Subcutaneous Medicine Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Subcutaneous Medicine Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Medicine Delivery Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Subcutaneous Medicine Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Subcutaneous Medicine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2019-2024)
Table 19. Global Subcutaneous Medicine Delivery Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2025-2030)
Table 21. Global Subcutaneous Medicine Delivery Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Subcutaneous Medicine Delivery Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Subcutaneous Medicine Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Subcutaneous Medicine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Subcutaneous Medicine Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Subcutaneous Medicine Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Subcutaneous Medicine Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2019-2024)
Table 53. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2025-2030)
Table 54. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 59. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Type (2025-2030)
Table 60. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2019-2024)
Table 63. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2025-2030)
Table 64. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Application (2019-2024)
Table 69. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Application (2025-2030)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Eli Lily Corporation Information
Table 76. Eli Lily Description and Business Overview
Table 77. Eli Lily Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lily Subcutaneous Medicine Delivery Devices Product
Table 79. Eli Lily Recent Developments/Updates
Table 80. Galaxo Corporation Information
Table 81. Galaxo Description and Business Overview
Table 82. Galaxo Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Galaxo Subcutaneous Medicine Delivery Devices Product
Table 84. Galaxo Recent Developments/Updates
Table 85. HMD pharmaceuticals Corporation Information
Table 86. HMD pharmaceuticals Description and Business Overview
Table 87. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product
Table 89. HMD pharmaceuticals Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Subcutaneous Medicine Delivery Devices Product
Table 94. Merck Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Subcutaneous Medicine Delivery Devices Product
Table 99. Novartis Recent Developments/Updates
Table 100. Novo Nordisk Corporation Information
Table 101. Novo Nordisk Description and Business Overview
Table 102. Novo Nordisk Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Novo Nordisk Subcutaneous Medicine Delivery Devices Product
Table 104. Novo Nordisk Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Subcutaneous Medicine Delivery Devices Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Sanofi Subcutaneous Medicine Delivery Devices Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Teva Pharmaceutical Corporation Information
Table 116. Teva Pharmaceutical Description and Business Overview
Table 117. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product
Table 119. Teva Pharmaceutical Recent Developments/Updates
Table 120. Zogenix Corporation Information
Table 121. Zogenix Description and Business Overview
Table 122. Zogenix Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Zogenix Subcutaneous Medicine Delivery Devices Product
Table 124. Zogenix Recent Developments/Updates
Table 125. BD Corporation Information
Table 126. BD Description and Business Overview
Table 127. BD Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. BD Subcutaneous Medicine Delivery Devices Product
Table 129. BD Recent Developments/Updates
Table 130. West Pharmaceutical Services Corporation Information
Table 131. West Pharmaceutical Services Description and Business Overview
Table 132. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product
Table 134. West Pharmaceutical Services Recent Developments/Updates
Table 135. Ypsomed AG Corporation Information
Table 136. Ypsomed AG Description and Business Overview
Table 137. Ypsomed AG Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Ypsomed AG Subcutaneous Medicine Delivery Devices Product
Table 139. Ypsomed AG Recent Developments/Updates
Table 140. Elcam Medical Corporation Information
Table 141. Elcam Medical Description and Business Overview
Table 142. Elcam Medical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Elcam Medical Subcutaneous Medicine Delivery Devices Product
Table 144. Elcam Medical Recent Developments/Updates
Table 145. Amgen Corporation Information
Table 146. Amgen Description and Business Overview
Table 147. Amgen Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Amgen Subcutaneous Medicine Delivery Devices Product
Table 149. Amgen Recent Developments/Updates
Table 150. Wilhelm Haselmeier Corporation Information
Table 151. Wilhelm Haselmeier Description and Business Overview
Table 152. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product
Table 154. Wilhelm Haselmeier Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Subcutaneous Medicine Delivery Devices Distributors List
Table 158. Subcutaneous Medicine Delivery Devices Customers List
Table 159. Subcutaneous Medicine Delivery Devices Market Trends
Table 160. Subcutaneous Medicine Delivery Devices Market Drivers
Table 161. Subcutaneous Medicine Delivery Devices Market Challenges
Table 162. Subcutaneous Medicine Delivery Devices Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Subcutaneous Medicine Delivery Devices
Figure 2. Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Subcutaneous Medicine Delivery Devices Market Share by Type in 2023 & 2030
Figure 4. Implantable Subcutaneous Medicine Delivery Device Product Picture
Figure 5. Injection Type Subcutaneous Medicine Delivery Device Product Picture
Figure 6. Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Subcutaneous Medicine Delivery Devices Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Subcutaneous Medicine Delivery Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Subcutaneous Medicine Delivery Devices Market Size (2019-2030) & (US$ Million)
Figure 13. Global Subcutaneous Medicine Delivery Devices Sales (2019-2030) & (K Units)
Figure 14. Global Subcutaneous Medicine Delivery Devices Average Price (USD/Unit) & (2019-2030)
Figure 15. Subcutaneous Medicine Delivery Devices Report Years Considered
Figure 16. Subcutaneous Medicine Delivery Devices Sales Share by Manufacturers in 2023
Figure 17. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Subcutaneous Medicine Delivery Devices Players: Market Share by Revenue in 2023
Figure 19. Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Subcutaneous Medicine Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2019-2030)
Figure 22. North America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 23. United States Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2019-2030)
Figure 26. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 27. Germany Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2019-2030)
Figure 34. China Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2019-2030)
Figure 44. Latin America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Subcutaneous Medicine Delivery Devices by Type (2019-2030)
Figure 54. Global Revenue Market Share of Subcutaneous Medicine Delivery Devices by Type (2019-2030)
Figure 55. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Subcutaneous Medicine Delivery Devices by Application (2019-2030)
Figure 57. Global Revenue Market Share of Subcutaneous Medicine Delivery Devices by Application (2019-2030)
Figure 58. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Application (2019-2030)
Figure 59. Subcutaneous Medicine Delivery Devices Value Chain
Figure 60. Subcutaneous Medicine Delivery Devices Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
